MétaCan
Menu
Back to cohort
Record W2157776316 · doi:10.1517/17425250903273160

Saquinavir, the pioneer antiretroviral protease inhibitor

2009· review· en· W2157776316 on OpenAlexaff
Charles JL la Porte

Bibliographic record

VenueExpert Opinion on Drug Metabolism & Toxicology · 2009
Typereview
Languageen
FieldMedicine
TopicHIV/AIDS drug development and treatment
Canadian institutionsUniversity of OttawaOttawa Hospital
Fundersnot available
KeywordsSaquinavirTolerabilityProtease inhibitor (pharmacology)MedicinePillPharmacologyHuman immunodeficiency virus (HIV)Antiretroviral therapyProteaseANTIRETROVIRAL AGENTSIntensive care medicineVirologyViral loadAdverse effectBiology

Abstract

fetched live from OpenAlex

BACKGROUND: The treatment of HIV infection underwent a major change in 1995 when saquinavir was the first protease inhibitor introduced into the market. This drug made the use of combination therapy in the treatment of HIV possible and increased the success rate of treatment. OBJECTIVE: This article will review recent literature on saquinavir to define its current role in HIV treatment, among the newer antiretroviral drugs. METHODS: Scientific literature and conference presentations were evaluated for relevant information pertaining to saquinavir. RESULTS/CONCLUSIONS: Although underused, saquinavir has good efficacy and tolerability when compared to other protease inhibitors. The film-coated tablet formulation improved pill burden. Saquinavir still has potential in the treatment of adults, children and pregnant women.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.885
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0000.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.042
GPT teacher head0.356
Teacher spread0.314 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations35
Published2009
Admission routes1
Has abstractyes

Explore more

Same venueExpert Opinion on Drug Metabolism & ToxicologySame topicHIV/AIDS drug development and treatmentFrench-language works237,207